Purpose: To report a case series of anterior uveitis after laser in situ keratomileusis (LASIK) and the incidence of anterior uveitis at a mean of 3 years.
Setting: Centro Medico Docente La Trinidad and Clinica Oftalmologica Centro Caracas, Caracas, Venezuela.
Methods: Five refractive surgeons and 18488 eyes that had surgical correction of a mean ametropia of -2.23 diopters (D) (range -10.25 to +4.25 D) participated in the study; 74.3% of the eyes were myopic. Laser in situ keratomileusis was performed in all eyes. Patients were followed for a mean of 36 months (range 6 to 48 months) after LASIK. The clinical charts of patients who developed uveitis after LASIK were reviewed. The mean preoperative intraocular pressure (IOP) was 15.2 mm Hg (range 12 to 19 mm Hg). The mean corneal ablation depth was 37.47 micro m (range 12 to 98 micro m). In the immediate postoperative period, all patients received a combination of topical dexamethasone and tobramycin.
Results: Thirty-five eyes (18 patients) developed anterior uveitis after LASIK. Signs and symptoms appeared a mean of 20.7 days (range 17 to 28 days) postoperatively and 5.08 days (range 2 to 8 days) after withdrawal of topical steroid and antibiotic agents. Eyes that developed LASIK-related uveitis had a mean preoperative spherical equivalent of -2.32 D (range -7.00 to +4.25 D). Intraocular pressure dropped to a mean of 8.0 mm Hg (range 4 to 12 mm Hg) at the onset of uveitis (P <.0001). The LASIK-related anterior uveitis resolved and IOP returned to baseline after a mean of 3 days on topical steroid and cycloplegic agents. Laboratory and immunology (including human leukocyte antigen-B27) tests were negative in 15 of 18 patients (83.33%). The incidence of uveitis after LASIK was 0.18%.
Conclusions: Anterior uveitis after LASIK is infrequent. It may be due to uveal trauma during surgery with disruption of normal anterior-chamber-associated immune deviation, decreased antiinflammatory cytokines, and increased proinflammatory cytokines. Further studies are needed to investigate the mechanisms of this association.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0886-3350(02)01364-0 | DOI Listing |
BMC Pregnancy Childbirth
January 2025
Department of Obstetrics and Gynecology, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Longmatan Disrict, Chunhui Road 182, Luzhou, Sichuan, 646000, China.
Background: Behçet's disease (BD) during pregnancy is a relatively rare condition, and there are currently no established guidelines for its management. The effects of BD on both mothers and children remain unclear. In this paper, we present the diagnostic and treatment processes for a patient with BD during pregnancy.
View Article and Find Full Text PDFInt Ophthalmol
January 2025
Department of Ophthalmology, University Hospital Fundación Jiménez Díaz, Madrid, Spain.
Purpose: To evaluate the efficacy of sulfasalazine (SSZ) for recurrent acute anterior uveitis (AAU).
Methods: Retrospective chart review of patients diagnosed with recurrent AAU treated with SSZ from January 2008 to September 2023. The grading of uveitis activity was defined as per SUN working group.
BMC Ophthalmol
January 2025
Department of Ophthalmology, Tokyo Women's Medical University, 8-1 Kawadacho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Background: To report a case of intraocular inflammation (IOI) after intravitreal injection of aflibercept 8 mg for treatment-refractory neovascular age-related macular degeneration.
Case Presentation: An 80-year-old man with diabetes mellitus had neovascular age-related macular degeneration refractory to treatment with aflibercept 2 mg. Despite ten injections of faricimab, the exudation remained, and we switched to brolucizumab, which resulted in a mild IOI.
Front Immunol
January 2025
Department of Rheumatology & Allergology, Japanese Red Cross Medical Center, Tokyo, Japan.
Patients with A20 haploinsufficiency (HA20) presenting with central nervous system (CNS) symptoms are rare, and available reports are limited. Here, we describe a patient with HA20, previously followed up as Behçet disease, who presented with CNS symptoms in adulthood. A 38-year-old Japanese male who had been followed up for incomplete Behçet disease at another hospital since 28 years of age presented to our hospital with acute-onset diplopia and persistent hiccups that were severe enough to cause vomiting.
View Article and Find Full Text PDFBMC Ophthalmol
January 2025
Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Purpose: Proliferative vitreoretinopathy (PVR) is a complication of retinal detachment which requires multiple vitreoretinal surgical interventions and frequent use of oil endotamponade. In this study, we conducted an in-depth analysis of complications associated with the use of heavy silicone oil in the management of inferior PVR.
Methods: A retrospective cohort study of 20 eyes that underwent vitrectomy for inferior PVR with use of heavy silicone oil (Densiron 68) between March 2021 and October 2022 at Oxford Eye Hospital.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!